Bio Protocol has successfully raised $6.9 million in a funding round led by Arthur Hayes' Maelstrom Fund. The round also saw participation from Mechanism Capital, Animoca Brands, and Presto Labs. Bio Protocol is focused on developing an AI-native decentralized research platform. The latest version, Bio V2, introduces on-chain financing mechanisms and AI research agents known as BioAgents.
Bio Protocol Secures $6.9 Million in Funding Led by Maelstrom Fund
Disclaimer: The content provided on Phemex News is for informational purposes only. We do not guarantee the quality, accuracy, or completeness of the information sourced from third-party articles. The content on this page does not constitute financial or investment advice. We strongly encourage you to conduct you own research and consult with a qualified financial advisor before making any investment decisions.